SMAD7 and rectal cancer: A study investigating susceptibility loci, which could predict rectal cancer prognosis after surgery, confirmed that the rs12953717 and rs4464148 variants are significantly associated with rectal cancer recurrence and patients with lower Smad7 expression exhibit a longer disease-free survival [94].